Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Vaccines Administered Orally
1.2 Key Market Segments
1.2.1 Human Vaccines Administered Orally Segment by Type
1.2.2 Human Vaccines Administered Orally Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Vaccines Administered Orally Market Overview
2.1 Global Market Overview
2.1.1 Global Human Vaccines Administered Orally Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Human Vaccines Administered Orally Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Vaccines Administered Orally Market Competitive Landscape
3.1 Global Human Vaccines Administered Orally Sales by Manufacturers (2019-2024)
3.2 Global Human Vaccines Administered Orally Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Vaccines Administered Orally Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Vaccines Administered Orally Sales Sites, Area Served, Product Type
3.6 Human Vaccines Administered Orally Market Competitive Situation and Trends
3.6.1 Human Vaccines Administered Orally Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Vaccines Administered Orally Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Vaccines Administered Orally Industry Chain Analysis
4.1 Human Vaccines Administered Orally Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Vaccines Administered Orally Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Vaccines Administered Orally Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Vaccines Administered Orally Sales Market Share by Type (2019-2024)
6.3 Global Human Vaccines Administered Orally Market Size Market Share by Type (2019-2024)
6.4 Global Human Vaccines Administered Orally Price by Type (2019-2024)
7 Human Vaccines Administered Orally Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Vaccines Administered Orally Market Sales by Application (2019-2024)
7.3 Global Human Vaccines Administered Orally Market Size (M USD) by Application (2019-2024)
7.4 Global Human Vaccines Administered Orally Sales Growth Rate by Application (2019-2024)
8 Human Vaccines Administered Orally Market Consumption by Region
8.1 Global Human Vaccines Administered Orally Sales by Region
8.1.1 Global Human Vaccines Administered Orally Sales by Region
8.1.2 Global Human Vaccines Administered Orally Sales Market Share by Region
8.2 North America
8.2.1 North America Human Vaccines Administered Orally Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Vaccines Administered Orally Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Vaccines Administered Orally Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Vaccines Administered Orally Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Vaccines Administered Orally Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Human Vaccines Administered Orally Market Production by Region
9.1 Global Production of Human Vaccines Administered Orally by Region (2019-2024)
9.2 Global Human Vaccines Administered Orally Revenue Market Share by Region (2019-2024)
9.3 Global Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Human Vaccines Administered Orally Production
9.4.1 North America Human Vaccines Administered Orally Production Growth Rate (2019-2024)
9.4.2 North America Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Human Vaccines Administered Orally Production
9.5.1 Europe Human Vaccines Administered Orally Production Growth Rate (2019-2024)
9.5.2 Europe Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Human Vaccines Administered Orally Production (2019-2024)
9.6.1 Japan Human Vaccines Administered Orally Production Growth Rate (2019-2024)
9.6.2 Japan Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Human Vaccines Administered Orally Production (2019-2024)
9.7.1 China Human Vaccines Administered Orally Production Growth Rate (2019-2024)
9.7.2 China Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Merck
10.1.1 Merck Human Vaccines Administered Orally Basic Information
10.1.2 Merck Human Vaccines Administered Orally Product Overview
10.1.3 Merck Human Vaccines Administered Orally Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck Human Vaccines Administered Orally SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Human Vaccines Administered Orally Basic Information
10.2.2 GSK Human Vaccines Administered Orally Product Overview
10.2.3 GSK Human Vaccines Administered Orally Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK Human Vaccines Administered Orally SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi
10.3.1 Sanofi Human Vaccines Administered Orally Basic Information
10.3.2 Sanofi Human Vaccines Administered Orally Product Overview
10.3.3 Sanofi Human Vaccines Administered Orally Product Market Performance
10.3.4 Sanofi Human Vaccines Administered Orally SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Human Vaccines Administered Orally Basic Information
10.4.2 Lanzhou Institute Human Vaccines Administered Orally Product Overview
10.4.3 Lanzhou Institute Human Vaccines Administered Orally Product Market Performance
10.4.4 Lanzhou Institute Business Overview
10.4.5 Lanzhou Institute Recent Developments
10.5 Serum Institute
10.5.1 Serum Institute Human Vaccines Administered Orally Basic Information
10.5.2 Serum Institute Human Vaccines Administered Orally Product Overview
10.5.3 Serum Institute Human Vaccines Administered Orally Product Market Performance
10.5.4 Serum Institute Business Overview
10.5.5 Serum Institute Recent Developments
10.6 Valneva
10.6.1 Valneva Human Vaccines Administered Orally Basic Information
10.6.2 Valneva Human Vaccines Administered Orally Product Overview
10.6.3 Valneva Human Vaccines Administered Orally Product Market Performance
10.6.4 Valneva Business Overview
10.6.5 Valneva Recent Developments
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Human Vaccines Administered Orally Basic Information
10.7.2 Shanghai United Cell Human Vaccines Administered Orally Product Overview
10.7.3 Shanghai United Cell Human Vaccines Administered Orally Product Market Performance
10.7.4 Shanghai United Cell Business Overview
10.7.5 Shanghai United Cell Recent Developments
10.8 Bibcol
10.8.1 Bibcol Human Vaccines Administered Orally Basic Information
10.8.2 Bibcol Human Vaccines Administered Orally Product Overview
10.8.3 Bibcol Human Vaccines Administered Orally Product Market Performance
10.8.4 Bibcol Business Overview
10.8.5 Bibcol Recent Developments
10.9 PaxVax
10.9.1 PaxVax Human Vaccines Administered Orally Basic Information
10.9.2 PaxVax Human Vaccines Administered Orally Product Overview
10.9.3 PaxVax Human Vaccines Administered Orally Product Market Performance
10.9.4 PaxVax Business Overview
10.9.5 PaxVax Recent Developments
10.10 Vabiotech
10.10.1 Vabiotech Human Vaccines Administered Orally Basic Information
10.10.2 Vabiotech Human Vaccines Administered Orally Product Overview
10.10.3 Vabiotech Human Vaccines Administered Orally Product Market Performance
10.10.4 Vabiotech Business Overview
10.10.5 Vabiotech Recent Developments
10.11 Tiantan Biological
10.11.1 Tiantan Biological Human Vaccines Administered Orally Basic Information
10.11.2 Tiantan Biological Human Vaccines Administered Orally Product Overview
10.11.3 Tiantan Biological Human Vaccines Administered Orally Product Market Performance
10.11.4 Tiantan Biological Business Overview
10.11.5 Tiantan Biological Recent Developments
10.12 EuBiologics
10.12.1 EuBiologics Human Vaccines Administered Orally Basic Information
10.12.2 EuBiologics Human Vaccines Administered Orally Product Overview
10.12.3 EuBiologics Human Vaccines Administered Orally Product Market Performance
10.12.4 EuBiologics Business Overview
10.12.5 EuBiologics Recent Developments
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Human Vaccines Administered Orally Basic Information
10.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Product Overview
10.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Product Market Performance
10.13.4 Panacea Biotec Ltd Business Overview
10.13.5 Panacea Biotec Ltd Recent Developments
10.14 Bio-Med
10.14.1 Bio-Med Human Vaccines Administered Orally Basic Information
10.14.2 Bio-Med Human Vaccines Administered Orally Product Overview
10.14.3 Bio-Med Human Vaccines Administered Orally Product Market Performance
10.14.4 Bio-Med Business Overview
10.14.5 Bio-Med Recent Developments
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Basic Information
10.15.2 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Overview
10.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Market Performance
10.15.4 Halfkin Bio-Pharmaceuticals Business Overview
10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 Human Vaccines Administered Orally Market Forecast by Region
11.1 Global Human Vaccines Administered Orally Market Size Forecast
11.2 Global Human Vaccines Administered Orally Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Vaccines Administered Orally Market Size Forecast by Country
11.2.3 Asia Pacific Human Vaccines Administered Orally Market Size Forecast by Region
11.2.4 South America Human Vaccines Administered Orally Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Human Vaccines Administered Orally by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Human Vaccines Administered Orally Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Human Vaccines Administered Orally by Type (2025-2032)
12.1.2 Global Human Vaccines Administered Orally Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Human Vaccines Administered Orally by Type (2025-2032)
12.2 Global Human Vaccines Administered Orally Market Forecast by Application (2025-2032)
12.2.1 Global Human Vaccines Administered Orally Sales (K MT) Forecast by Application
12.2.2 Global Human Vaccines Administered Orally Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
